Bnp Paribas Arbitrage, Snc »

Halozyme Therapeutics shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2023-12-31 $206k 238k 0.86
2022-12-31 $4.6M 4.7M 0.97

More positions owned by Bnp Paribas Arbitrage, Snc

Amazon.com Equity (AMZN)
Apple Equity (AAPL)
Microsoft Corp Equity (MSFT)
NVIDIA Corp Equity (NVDA)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Meta Platforms Equity (META)
NASDAQ 100 Index Fund (QQQ)
Industrial Select Sector SPDR Fund Fund (XLI)
SPDR S&P 500 ETF Trust Fund (SPY)
Visa Equity (V)
Berkshire Hathaway Equity (BRK.B)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOGL)
Advanced Micro Devices Equity (AMD)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Halozyme Therapeutics

Wellesley Investment Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Citigroup
Aviva
Citadel Advisors
D. E. Shaw & Co
Wells Fargo & Company
Readystate Asset Management
Tenor Capital Management
Wolverine Asset Management
Victory Capital Management
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management

View all funds holding Halozyme Therapeutics